179 related articles for article (PubMed ID: 16598395)
1. Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients.
Picard F; Brehm M; Fassbach M; Pelzer B; Scheuring S; Küry P; Strauer BE; Schwartzkopff B
Clin Res Cardiol; 2006 May; 95(5):261-9. PubMed ID: 16598395
[TBL] [Abstract][Full Text] [Related]
2. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
[TBL] [Abstract][Full Text] [Related]
4. Collagen I and III, MMP-1 and TIMP-1 immunoexpression in dilated cardiomyopathy.
Mihailovici AR; Deliu RC; Mărgăritescu C; Simionescu CE; Donoiu I; Istrătoaie O; Tudoraşcu DR; Târtea EA; Gheonea DI
Rom J Morphol Embryol; 2017; 58(3):777-781. PubMed ID: 29250654
[TBL] [Abstract][Full Text] [Related]
5. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C
Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947
[TBL] [Abstract][Full Text] [Related]
6. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
Yokoseki O; Yazaki Y; Suzuki J; Imamura H; Takenaka H; Isobe M
Jpn Circ J; 2000 May; 64(5):352-7. PubMed ID: 10834450
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression of extracellular matrix components in dilated cardiomyopathy.
Tyagi SC; Kumar S; Voelker DJ; Reddy HK; Janicki JS; Curtis JJ
J Cell Biochem; 1996 Nov; 63(2):185-98. PubMed ID: 8913870
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
Antonov IB; Kozlov KL; Pal'tseva EM; Polyakova OV; Lin'kova NS
Bull Exp Biol Med; 2018 Mar; 164(4):550-553. PubMed ID: 29504111
[TBL] [Abstract][Full Text] [Related]
9. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].
Zhang M; Cheng K; Yu L; Wu W; Wang Y; Chen Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):640-645. PubMed ID: 35924522
[TBL] [Abstract][Full Text] [Related]
11. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
12. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
[TBL] [Abstract][Full Text] [Related]
14. The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy.
Fonfara S; Hetzel U; Oyama MA; Kipar A
Vet J; 2014 Mar; 199(3):406-12. PubMed ID: 24440442
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
17. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
[TBL] [Abstract][Full Text] [Related]
20. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
